To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

158.252 days ago
161.792 days ago
arrow

LOWER/UPPER CIRCUITS

128.88
193.33
arrow
Kopran Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 44.29%
Net profit growth 5Y CAGR : 16.23%
Kopran Ltd Top mutual funds holding
arrow
Kopran Limited is engaged primarily in pharmaceuticals business. The Company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms. The Company’s Finished Dosage Forms covers the needs of International markets with a range of more than 100 dosage forms including Tablets Capsules Dry Powder Suspension and Injectables. The Company’s facility is located at Khopoli Raigad District Maharashtra. The Company manufactures a range of Active Pharmaceutical Ingredients including Sterile Cephalosporins. The Company also provides a range of specialty products which include Macrolides and Cardiovascular range among others. The Company’s subsidiaries include Kopran Research Laboratories Ltd. Kopran (H.K) Ltd. and Kopran Lifesciences Ltd..The company also engagged in the business of Pharmaceuticals Consumer Care Division.
personal

Grow your wealth with more research recommendations

+91